価格表

在庫・価格 : 2024年05月02日 02時43分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-SARS-CoV-2 (COVID-19) Spike S1, Rabbit-Mono(HL6)
データシート
GTX635654 GNTジーンテックス
GeneTex International Corporation
100 μl ¥75,000 1個 追加

在庫・価格 : 2024年05月02日 02時43分 現在

Anti-SARS-CoV-2 (COVID-19) Spike S1, Rabbit-Mono(HL6)

  • 商品コード:GTX635654
  • メーカー:GNT
  • 包装:100μl
  • 価格: ¥75,000
  • 在庫:1個
使用文献
No. 文献情報 備考 参照
1 Manト稿k-Keber M et al. Disruption of disulfides within RBD of SARS-CoV-2 spike protein prevents fusion and represents a target for viral entry inhibition by registered drugs. FASEB J 2021 06;35(6):e21651
Manト稿k-Keber M et al
2021/01/01
PubMed
2 Motozono C et al. SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity. Cell Host Microbe 2021 07;29(7):1124-1136.e11
Motozono C et al
2021/01/01
PubMed
3 Danics K et al. A COVID-19-association-dependent categorization of death causes in 100 autopsy cases. Geroscience 2021 10;43(5):2265-2287
Danics K et al
2021/01/01
PubMed
4 Song Z et al. Integrated histopathological, lipidomic, and metabolomic profiles reveal mink is a useful animal model to mimic the pathogenicity of severe COVID-19 patients. Signal Transduct Target Ther 2022 01;7(1):29
Song Z et al
2022/01/01
PubMed
5 Park SB et al. Targeting the Fusion Process of SARS-CoV-2 Infection by Small Molecule Inhibitors. mBio 2022 Jan;:e0323821
Park SB et al
2022/01/01
PubMed
6 Saito A et al. Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation. Nature 2022 02;602(7896):300-306
Saito A et al
2022/01/01
PubMed
7 Kim HK et al. Generation of human tonsil epithelial organoids as an ex vivo model for SARS-CoV-2 infection. Biomaterials 2022 Apr;283:121460
Kim HK et al
2022/01/01
PubMed
8 Chen Y et al. Quantitative and Ultrasensitive In-situ Immunoassay Technology for SARS-CoV-2 Detection in Saliva. Res Sq 2021 Jan;
Chen Y et al
2021/01/01
PubMed
9 Reagan-Steiner S et al. Detection of SARS-CoV-2 in Neonatal Autopsy Tissues and Placenta. Emerg Infect Dis 2022 Mar;28(3):510-517
Reagan-Steiner S et al
2022/01/01
PubMed
10 Deng W et al. Sequential immunizations confer cross-protection against variants of SARS-CoV-2, including Omicron in Rhesus macaques. Signal Transduct Target Ther 2022 Apr;7(1):124
Deng W et al
2022/01/01
PubMed
11 Chen Y et al. Quantitative and ultrasensitive in situ immunoassay technology for SARS-CoV-2 detection in saliva. Sci Adv 2022 May;8(21):eabn3481
Chen Y et al
2022/01/01
PubMed
12 T Iida et al., High-throughput Light-induced Immunoassay under One-minute Antibody-coating with Energy Saving Nanoparticle-imprinted Substrate, Research Square., 2024., ().,

PubMed
  • No.: 1
  • 文献情報:
    Manト稿k-Keber M et al. Disruption of disulfides within RBD of SARS-CoV-2 spike protein prevents fusion and represents a target for viral entry inhibition by registered drugs. FASEB J 2021 06;35(6):e21651
    Manト稿k-Keber M et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Motozono C et al. SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity. Cell Host Microbe 2021 07;29(7):1124-1136.e11
    Motozono C et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Danics K et al. A COVID-19-association-dependent categorization of death causes in 100 autopsy cases. Geroscience 2021 10;43(5):2265-2287
    Danics K et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Song Z et al. Integrated histopathological, lipidomic, and metabolomic profiles reveal mink is a useful animal model to mimic the pathogenicity of severe COVID-19 patients. Signal Transduct Target Ther 2022 01;7(1):29
    Song Z et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Park SB et al. Targeting the Fusion Process of SARS-CoV-2 Infection by Small Molecule Inhibitors. mBio 2022 Jan;:e0323821
    Park SB et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Saito A et al. Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation. Nature 2022 02;602(7896):300-306
    Saito A et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Kim HK et al. Generation of human tonsil epithelial organoids as an ex vivo model for SARS-CoV-2 infection. Biomaterials 2022 Apr;283:121460
    Kim HK et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Chen Y et al. Quantitative and Ultrasensitive In-situ Immunoassay Technology for SARS-CoV-2 Detection in Saliva. Res Sq 2021 Jan;
    Chen Y et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Reagan-Steiner S et al. Detection of SARS-CoV-2 in Neonatal Autopsy Tissues and Placenta. Emerg Infect Dis 2022 Mar;28(3):510-517
    Reagan-Steiner S et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Deng W et al. Sequential immunizations confer cross-protection against variants of SARS-CoV-2, including Omicron in Rhesus macaques. Signal Transduct Target Ther 2022 Apr;7(1):124
    Deng W et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Chen Y et al. Quantitative and ultrasensitive in situ immunoassay technology for SARS-CoV-2 detection in saliva. Sci Adv 2022 May;8(21):eabn3481
    Chen Y et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    T Iida et al., High-throughput Light-induced Immunoassay under One-minute Antibody-coating with Energy Saving Nanoparticle-imprinted Substrate, Research Square., 2024., ().,

  • 備考:
  • 参照:
    PubMed